MEDCLMedinCell S.A.
24.72EUR+2.49%Mkt Cap: 971.17M $P/E:

MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting in…

Key Statistics

Company
Market Cap971.17M $
Enterprise Value927.48M $
Revenue (TTM)26.39M $
Gross Profit21.22M $
Net Income (TTM)-34.01M $
Revenue/Share0.7913 USD
Last Price24.72 EUR
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees141
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0004065605
Valuation
P/E (Trailing)
P/E (Forward)57.43
PEG
EV/EBITDA-42.58
EV/Revenue35.15
P/S35.68
P/B283.76
EPS (TTM)-0.94
EPS (Forward)0.42
52W Range
16.6435% of range39.68
52W High39.68 EUR
52W Low16.64 EUR
Profitability
Gross Margin100.00%
Oper. Margin-139.50%
EBITDA Margin-82.54%
Profit Margin-160.27%
ROE-1021.12%
ROA-28.95%
Growth
Revenue Growth-44.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-26.69M $
CapEx (TTM)2.22M $
FCF Margin-81.49%
FCF Yield-2.21%
Net Debt-14.03M $
Net Debt/EBITDA0.64
Balance Sheet
Debt/Equity18.74
Current Ratio4.67
Quick Ratio4.59
Book Value/Sh0.0850 EUR
Cash/Share2.362 EUR
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 EUR
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)34.51 EUR
Upside (mean)+39.6%
Target Range30.00 EUR39.00 EUR
30.00+39.6% to mean39.00
# Analysts9
Ownership
Shares Out.35.91M
Float32.79M
Insiders33.99%
Institutions31.72%
Technical
SMA 5026.10 (-5.3%)
SMA 20025.48 (-3.0%)
Beta0.98
S&P 52W Chg18.16%
Avg Vol (30d)46.25K
Avg Vol (10d)42.68K
Technical Indicators
RSI (14)41.2
MACD-0.5012
MACD Signal-0.4993
MACD Hist.-0.0019
BB Upper26.55 EUR
BB Middle25.05 EUR
BB Lower23.54 EUR
BB Width12.02%
ATR (14)0.9735 EUR
Vol Ratio (20d)1.08x